SponsoredEndocrine Resistance Affects Patients' Time On 1st Line Treatment For HR+ mBC Patients. In HR+ mBC, Tumors May Become Endocrine Resistant Upon Exposure To 1L Treatment.
SponsoredWell-suited strategy for CAR lead discovery, selecting diverse desirable affinity leads. "All-inclusive CAR-T bioassay services from vector construction to functional assay"